366 related articles for article (PubMed ID: 26285873)
1. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
2. Tryptophan depletion in context of the inflammatory and general nutritional status of a low-income South African HIV-infected population.
Bipath P; Levay PF; Viljoen M
J Health Popul Nutr; 2016 Feb; 35():5. PubMed ID: 26887418
[TBL] [Abstract][Full Text] [Related]
3. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
4. Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS.
Brown RR; Ozaki Y; Datta SP; Borden EC; Sondel PM; Malone DG
Adv Exp Med Biol; 1991; 294():425-35. PubMed ID: 1722946
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
6. Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients.
Huengsberg M; Winer JB; Gompels M; Round R; Ross J; Shahmanesh M
Clin Chem; 1998 Apr; 44(4):858-62. PubMed ID: 9554499
[TBL] [Abstract][Full Text] [Related]
7. Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.
Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP
J Neuroimmunol; 1992 Sep; 40(1):71-80. PubMed ID: 1387655
[TBL] [Abstract][Full Text] [Related]
8. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
[TBL] [Abstract][Full Text] [Related]
9. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
Saito K; Markey SP; Heyes MP
Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
[TBL] [Abstract][Full Text] [Related]
10. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.
Heyes MP; Saito K; Crowley JS; Davis LE; Demitrack MA; Der M; Dilling LA; Elia J; Kruesi MJ; Lackner A
Brain; 1992 Oct; 115 ( Pt 5)():1249-73. PubMed ID: 1422788
[TBL] [Abstract][Full Text] [Related]
11. Different kynurenine pathway enzymes limit quinolinic acid formation by various human cell types.
Heyes MP; Chen CY; Major EO; Saito K
Biochem J; 1997 Sep; 326 ( Pt 2)(Pt 2):351-6. PubMed ID: 9291104
[TBL] [Abstract][Full Text] [Related]
12. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and noncerebral malaria.
Sanni LA; Thomas SR; Tattam BN; Moore DE; Chaudhri G; Stocker R; Hunt NH
Am J Pathol; 1998 Feb; 152(2):611-9. PubMed ID: 9466588
[TBL] [Abstract][Full Text] [Related]
13. Tryptophan metabolism via the kynurenine pathway in patients with the eosinophilia-myalgia syndrome.
Silver RM; McKinley K; Smith EA; Quearry B; Harati Y; Sternberg EM; Heyes MP
Arthritis Rheum; 1992 Sep; 35(9):1097-105. PubMed ID: 1418026
[TBL] [Abstract][Full Text] [Related]
14. Reversal of the Kynurenine pathway of tryptophan catabolism may improve depression in ART-treated HIV-infected Ugandans.
Martinez P; Tsai AC; Muzoora C; Kembabazi A; Weiser SD; Huang Y; Haberer JE; Martin JN; Bangsberg DR; Hunt PW
J Acquir Immune Defic Syndr; 2014 Apr; 65(4):456-62. PubMed ID: 24220289
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms.
Fuchs D; Möller AA; Reibnegger G; Stöckle E; Werner ER; Wachter H
J Acquir Immune Defic Syndr (1988); 1990; 3(9):873-6. PubMed ID: 2166783
[TBL] [Abstract][Full Text] [Related]
16. Alterations in tryptophan metabolism in the toxic oil syndrome and in the eosinophilia-myalgia syndrome.
Silver RM; Sutherland SE; Carreira P; Heyes MP
J Rheumatol; 1992 Jan; 19(1):69-73. PubMed ID: 1532618
[TBL] [Abstract][Full Text] [Related]
17. Poliovirus induces indoleamine-2,3-dioxygenase and quinolinic acid synthesis in macaque brain.
Heyes MP; Saito K; Jacobowitz D; Markey SP; Takikawa O; Vickers JH
FASEB J; 1992 Aug; 6(11):2977-89. PubMed ID: 1322853
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
Saito K; Nowak TS; Markey SP; Heyes MP
J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
[TBL] [Abstract][Full Text] [Related]
19. 4-Chloro-3-hydroxyanthranilate, 6-chlorotryptophan and norharmane attenuate quinolinic acid formation by interferon-gamma-stimulated monocytes (THP-1 cells).
Saito K; Chen CY; Masana M; Crowley JS; Markey SP; Heyes MP
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):11-4. PubMed ID: 8471029
[TBL] [Abstract][Full Text] [Related]
20. Chronic effects of gamma-interferon on quinolinic acid and indoleamine-2,3-dioxygenase in brain of C57BL6 mice.
Saito K; Markey SP; Heyes MP
Brain Res; 1991 Apr; 546(1):151-4. PubMed ID: 1830237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]